Volume 69, Issue 1, Pages (July 2018)

Slides:



Advertisements
Similar presentations
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Advertisements

EASL Clinical Practice Guidelines: Vascular diseases of the liver Journal of Hepatology Volume 64, Issue 1, Pages (January 2016) DOI: /j.jhep
Omega 3 – Omega 6: What is right for the liver? Ashraf Mohammad El-Badry, Rolf Graf, Pierre-Alain Clavien Journal of Hepatology Volume 47, Issue 5, Pages.
Laurent Mailly, Mirjam B. Zeisel, Thomas F. Baumert 
Volume 61, Issue 2, Pages (August 2014)
Volume 63, Issue 1, Pages (July 2015)
Volume 59, Issue 1, Pages (July 2013)
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Volume 50, Issue 4, Pages (April 2009)
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
An integration of deep viral suppression with sequential immune modulation (cocktail therapy) to restore antiviral capacity: The future of chronic hepatitis.
Immunizations with hepatitis B viral antigens and a TLR7/8 agonist adjuvant induce antigen-specific immune responses in HBV-transgenic mice  Ying Wang,
Hepatic CD141+IFNλ+ DC subset: One against all?
R. Cavallo  Clinical Microbiology and Infection 
Volume 42, Issue 6, Pages (June 2005)
Halis Simsek, Ali Shorbagi, Yasemin Balaban, Gonca Tatar 
Volume 51, Issue 6, Pages (December 2009)
Reactive oxygen species in the normal and acutely injured liver
Bridget A. Robinson, Timothy J. Nice  Immunity 
Matthew T. Kitson, Stuart K. Roberts  Journal of Hepatology 
NS5A inhibitors in the treatment of hepatitis C
Immigration and viral hepatitis
Volume 61, Issue 3, Pages (September 2014)
The evidence supports a viral aetiology for primary biliary cirrhosis
Heidi Barth, Eric Robinet, T. Jake Liang, Thomas F. Baumert 
Living donor liver transplantation: is the hype over?
Reply to: “DCD consensus and futility in liver transplantation”
Introduction The American Journal of Medicine
Natural history and predictors of severity of chronic hepatitis C virus (HCV) and human immunodeficiency virus (HIV) co-infection  Anaïs Vallet-Pichard,
Evangelos Cholongitas, George V. Papatheodoridis, Andrew K. Burroughs 
Hepatitis C core protein – The “core” of immune deception?
Volume 61, Issue 1, Pages S108-S119 (November 2014)
Therapeutic vaccines and immune-based therapies for the treatment of chronic hepatitis B: Perspectives and challenges  Marie-Louise Michel, Qiang Deng,
Burcin Ekser, Eric Lagasse  Journal of Hepatology 
Marc van der Valk, Hans L. Zaaijer, Arnon P. Kater, Janke Schinkel 
Volume 68, Issue 3, Pages (March 2018)
Volume 39, Pages (January 2003)
Ming-Ling Chang, Yun-Fan Liaw  Journal of Hepatology 
Darius Moradpour, Arash Grakoui, Michael P. Manns 
Autophagy in the liver Journal of Hepatology
Volume 62, Issue 1, Pages (January 2015)
Connecting Mitochondria and Innate Immunity
In Vivo Role of pDCs in Regulating Adaptive Immunity
Rafael Esteban, Maria Buti  Gastroenterology 
Volume 60, Issue 6, Pages (June 2014)
Volume 50, Issue 4, Pages (April 2009)
Claire Z. Larter, Geoffrey C. Farrell  Journal of Hepatology 
Fei Xiao, Jane A. McKeating, Thomas F. Baumert  Journal of Hepatology 
Volume 67, Issue 5, Pages (November 2017)
Erratum The American Journal of Human Genetics
Volume 56, Issue 6, Pages (June 2012)
Immigration and viral hepatitis
Kornelius Schulze, Jean-Charles Nault, Augusto Villanueva 
Immunological techniques in viral hepatitis
The impact of intestinal microflora on serum bilirubin levels
Innate immunity and HCV
Volume 64, Issue 6, Pages (June 2016)
Volume 63, Issue 1, Pages (July 2015)
Close monitoring of serum HBV DNA levels and liver enzymes levels is most useful in the management of patients with occult HBV infection  Isabelle Chemin,
Volume 62, Issue 3, Pages (March 2015)
Volume 40, Issue 1, Pages (January 2004)
Volume 62, Issue 6, Pages (June 2015)
Ana Lleo, M. Eric Gershwin, Alberto Mantovani, Pietro Invernizzi 
Pathogenesis of cholestatic hepatitis C
Chimeric mouse model of hepatitis B virus infection
Volume 50, Issue 1, Pages 4-6 (January 2009)
Eric Robinet, Thomas F. Baumert  Journal of Hepatology 
Philippe Metz, Antje Reuter, Silke Bender, Ralf Bartenschlager 
Volume 44, Issue 4, Pages (April 2006)
Volume 64, Issue 6, Pages (June 2016)
Presentation transcript:

Volume 69, Issue 1, Pages 262-264 (July 2018) Erratum to “A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction” [J Hepatol 67 (2017) 669–679]  Lester Suárez-Amarán, Carla Usai, Marianna Di Scala, Cristina Godoy, Yi Ni, Mirja Hommel, Laura Palomo, Víctor Segura, Cristina Olagüe, Africa Vales, Alicia Ruiz-Ripa, Maria Buti, Eduardo Salido, Jesús Prieto, Stephan Urban, Francisco Rodríguez-Frias, Rafael Aldabe, Gloria González-Aseguinolaza  Journal of Hepatology  Volume 69, Issue 1, Pages 262-264 (July 2018) DOI: 10.1016/j.jhep.2018.04.003 Copyright © 2018 Terms and Conditions

Fig. 1 Infection of C57BL/6 mice with AAV-HBV/HDV gives rise to the production of circulating HDV infectious particles and a detectable humoral immune response against viral antigens, while anti-HBsAg and anti-HDAg humoral response is induced. (This figure appears in colour on the web.) Journal of Hepatology 2018 69, 262-264DOI: (10.1016/j.jhep.2018.04.003) Copyright © 2018 Terms and Conditions

Fig. 2 Infection of RAGB6 mice with AAV-HBV/HDV gives rise to the sustained production of circulating HDV infectious particles and HBV particles. (This figure appears in colour on the web.) Journal of Hepatology 2018 69, 262-264DOI: (10.1016/j.jhep.2018.04.003) Copyright © 2018 Terms and Conditions

Fig. 8 AAV-HDV infection induces an innate immune response that is partially dependent on MAVS. (This figure appears in colour on the web.) Journal of Hepatology 2018 69, 262-264DOI: (10.1016/j.jhep.2018.04.003) Copyright © 2018 Terms and Conditions